CD5(CD5/54/F6) Antibody |
|||
BNC700746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF770 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC700746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF770 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC810746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF680R conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC810746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF680R conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC800746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF680 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC800746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF680 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC550746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF555 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC550746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF555 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC430746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF543 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC430746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF543 conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC610746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF660R conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC610746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF660R conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC050746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF405M conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNC050746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), CF405M conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNCA0746-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD5(CD5/54/F6), APC conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNCAP0746-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD5(CD5/54/F6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNCAP0746-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD5(CD5/54/F6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNCP0746-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD5(CD5/54/F6), PerCP conjugate, Concentration: 0.1mg/mL |
CD5(CD5/54/F6) Antibody |
|||
BNCR0746-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD5(CD5/54/F6), RPE conjugate, Concentration: 0.1mg/mL |
CD5 antibody |
|||
10R-3625 | Fitzgerald | 100 ul | EUR 709 |
Description: Mouse monoclonal CD5 antibody |
CD5 antibody |
|||
10R-6336 | Fitzgerald | 100 ug | EUR 225 |
Description: Rat monoclonal CD5 antibody |
CD5 antibody |
|||
10R-6337 | Fitzgerald | 100 ug | EUR 219 |
Description: Mouse monoclonal CD5 antibody |
CD5 antibody |
|||
10R-CD5bFEp | Fitzgerald | 500 ug | EUR 427 |
Description: Mouse monoclonal CD5 antibody |
CD5 antibody |
|||
10R-CD5bMS | Fitzgerald | 500 ug | EUR 303 |
Description: Rat monoclonal CD5 antibody |
CD5 antibody |
|||
10R-CD5cMS | Fitzgerald | 100 ug | EUR 125 |
Description: Mouse monoclonal CD5 antibody |
CD5 antibody |
|||
10R-CD5gCKp | Fitzgerald | 500 ug | EUR 483.6 |
Description: Mouse monoclonal CD5 antibody |
CD5 Antibody |
|||
E046437 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
CD5 Antibody |
|||
E10-30400 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CD5 Antibody |
|||
E10-31706 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
CD5 Antibody |
|||
F43040-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: CD5 may act as a receptor in regulating T-cell proliferation. CD5 interacts with CD72/LYB-2. |
CD5 Antibody |
|||
F43040-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: CD5 may act as a receptor in regulating T-cell proliferation. CD5 interacts with CD72/LYB-2. |
CD5 Antibody |
|||
E315525 | EnoGene | 100ug/200ul | EUR 295 |
Description: Available in various conjugation types. |
CD5 Antibody |
|||
E76028 | EnoGene | 100μl | EUR 225 |
Description: Available in various conjugation types. |
CD5, Antibody |
|||
GWB-22D3B0 | GenWay Biotech | 0.1 mg | Ask for price |
CD5 Antibody |
|||
GWB-27A585 | GenWay Biotech | 1 mg | Ask for price |
CD5, Antibody |
|||
GWB-5D26F5 | GenWay Biotech | 7 ml | Ask for price |
CD5 Antibody |
|||
GWB-3A09D4 | GenWay Biotech | 0.1 mg | Ask for price |
CD5 Antibody |
|||
GWB-3D6A10 | GenWay Biotech | 0.1 mg | Ask for price |
CD5, Antibody |
|||
GWB-1D24E3 | GenWay Biotech | 1 ml | Ask for price |
CD5 Antibody |
|||
DF14431 | Affbiotech | 100ul | EUR 420 |
CD5 Antibody |
|||
DF14431-100ul | Affinity Biosciences | 100ul | EUR 280 |
CD5 Antibody |
|||
DF14431-200ul | Affinity Biosciences | 200ul | EUR 350 |
CD5 Antibody |
|||
E38PA9608 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CD5 Antibody |
|||
E38PA9728 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CD5 Antibody |
|||
1-CSB-PA001470 | Cusabio |
|
|
Description: A polyclonal antibody against CD5. Recognizes CD5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
CD5 Antibody |
|||
1-CSB-PA004942GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CD5. Recognizes CD5 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
CD5 Antibody |
|||
1-CSB-PA004942LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CD5. Recognizes CD5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200 |
CD5 Antibody |
|||
46437 | SAB | 100ul | EUR 319 |
CD5 Antibody |
|||
46437-100ul | SAB | 100ul | EUR 302.4 |
CD5 antibody |
|||
70R-16282 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal CD5 antibody |
CD5 antibody |
|||
70R-33486 | Fitzgerald | 100 ug | EUR 294 |
Description: Rabbit polyclonal CD5 antibody |
CD5 antibody |
|||
70R-6188 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal CD5 antibody raised against the N terminal of CD5 |
CD5 Antibody |
|||
BF0031 | Affbiotech | 200ul | EUR 540 |
CD5 antibody |
|||
GWB-B3AD81 | GenWay Biotech | 0.25 mg | Ask for price |
CD5 Antibody |
|||
GWB-999BB5 | GenWay Biotech | 0.1 ml | Ask for price |
CD5 Antibody |
|||
GWB-659D9B | GenWay Biotech | 0.2 mg | Ask for price |
CD5 Antibody |
|||
RQ5620 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: CD5 is a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. In humans, the gene is located on the long arm of chromosome 11. This protein is a type-I transmembrane glycoprotein found on the surface of thymocytes, T lymphocytes and a subset of B lymphocytes. The encoded protein contains three SRCR domains and may act as a receptor to regulate T-cell proliferation. Alternative splicing results in multiple transcript variants encoding different isoforms. |
Cd5 Antibody |
|||
RQ6376 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: CD5 is a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. In humans, the gene is located on the long arm of chromosome 11. This protein is a type-I transmembrane glycoprotein found on the surface of thymocytes, T lymphocytes and a subset of B lymphocytes. The encoded protein contains three SRCR domains and may act as a receptor to regulate T-cell proliferation. Alternative splicing results in multiple transcript variants encoding different isoforms. |
CD5 Antibody |
|||
RQ4443 | NSJ Bioreagents | 100ug | EUR 356.15 |
Description: CD5 is a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. In humans, the gene is located on the long arm of chromosome 11. This protein is a type-I transmembrane glycoprotein found on the surface of thymocytes, T lymphocytes and a subset of B lymphocytes. The encoded protein contains three SRCR domains and may act as a receptor to regulate T-cell proliferation. Alternative splicing results in multiple transcript variants encoding different isoforms. |
CD5 Antibody |
|||
RQ5134 | NSJ Bioreagents | 100ul | EUR 356.15 |
Description: This gene encodes a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. This protein is a type-I transmembrane glycoprotein found on the surface of thymocytes, T lymphocytes and a subset of B lymphocytes. The encoded protein contains three SRCR domains and may act as a receptor to regulate T-cell proliferation. Alternative splicing results in multiple transcript variants encoding different isoforms. [RefSeq] |
CD5 Antibody |
|||
RQ4028 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: CD5 is a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. In humans, the gene is located on the long arm of chromosome 11. This protein is a type-I transmembrane glycoprotein found on the surface of thymocytes, T lymphocytes and a subset of B lymphocytes. The encoded protein contains three SRCR domains and may act as a receptor to regulate T-cell proliferation. Alternative splicing results in multiple transcript variants encoding different isoforms. |
CD5 Antibody |
|||
GWB-ECB28D | GenWay Biotech | 1 ml | Ask for price |
CD5, Antibody |
|||
GWB-EE0AF3 | GenWay Biotech | 7 ml | Ask for price |
CD5 Antibody |
|||
GWB-MV250G | GenWay Biotech | 50ug | Ask for price |
CD5, Antibody |
|||
GWB-7FCEF7 | GenWay Biotech | 1 ml | Ask for price |
CD5 Antibody |
|||
GWB-F41D6E | GenWay Biotech | 200 TESTS | Ask for price |
CD5, Antibody |
|||
GWB-D19685 | GenWay Biotech | 0.1 ml | Ask for price |
CD5 Antibody |
|||
R20333-0.1ML | NSJ Bioreagents | 100ul | EUR 347.65 |
Description: T-cell surface glycoprotein CD5 may act as a receptor in regulating T-cell proliferation.[UniProt] |
CD5 Antibody |
|||
R20376-0.1ML | NSJ Bioreagents | 100ul | EUR 409 |
CD5 Antibody |
|||
P1041-01m | SAB | 0.1m | EUR 277.2 |
CD5 Antibody |
|||
P1041-1ml | SAB | 1ml | EUR 1086 |
CD5 Antibody |
|||
V9103-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V9103-20UG | NSJ Bioreagents | 20 ug | EUR 186.15 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V9103IHC-7ML | NSJ Bioreagents | 7 ml | EUR 424.15 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V9103SAF-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V3961-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V3961-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V3961SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7018-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: This antibody recognizes a 67kDa transmembrane protein, which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. antibody to CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. CD5 antibody detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. CD5 antibody is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, antibody to CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). CD5 antibody does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7018-20UG | NSJ Bioreagents | 20 ug | EUR 186.15 |
Description: This antibody recognizes a 67kDa transmembrane protein, which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. antibody to CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. CD5 antibody detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. CD5 antibody is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, antibody to CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). CD5 antibody does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7018SAF-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: This antibody recognizes a 67kDa transmembrane protein, which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. antibody to CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. CD5 antibody detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. CD5 antibody is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, antibody to CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). CD5 antibody does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7378-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7378-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7378IHC-7ML | NSJ Bioreagents | 7 ml | EUR 424.15 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7378SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7521-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7521-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7521IHC-7ML | NSJ Bioreagents | 7 ml | EUR 424.15 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V7521SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a 67kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
CD5 Antibody |
|||
V2035-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: This antibody recognizes a 67kDa transmembrane protein, which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. antibody to CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. CD5 antibody detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. CD5 antibody is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, antibody to CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). CD5 antibody does not react with granulocytes or monocytes. |